A detailed history of Ipswich Investment Management Co., Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Ipswich Investment Management Co., Inc. holds 72,408 shares of NVO stock, worth $10.4 Million. This represents 2.24% of its overall portfolio holdings.

Number of Shares
72,408
Previous 74,376 2.65%
Holding current value
$10.4 Million
Previous $7.69 Million 20.83%
% of portfolio
2.24%
Previous 2.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$102.11 - $135.92 $200,952 - $267,490
-1,968 Reduced 2.65%
72,408 $9.3 Million
Q4 2023

Jan 31, 2024

SELL
$87.78 - $105.45 $649,045 - $779,697
-7,394 Reduced 9.04%
74,376 $7.69 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $3.24 Million - $7.12 Million
35,665 Added 77.36%
81,770 $7.44 Million
Q2 2023

Jul 27, 2023

SELL
$155.98 - $172.65 $380,903 - $421,611
-2,442 Reduced 5.03%
46,105 $7.46 Million
Q1 2023

Apr 24, 2023

SELL
$132.34 - $159.14 $25,938 - $31,191
-196 Reduced 0.4%
48,547 $7.73 Million
Q4 2022

Feb 01, 2023

SELL
$102.55 - $135.33 $192,588 - $254,149
-1,878 Reduced 3.71%
48,743 $6.6 Million
Q3 2022

Oct 11, 2022

SELL
$95.28 - $116.93 $82,512 - $101,261
-866 Reduced 1.68%
50,621 $5.04 Million
Q2 2022

Jul 26, 2022

SELL
$103.24 - $121.81 $92,193 - $108,776
-893 Reduced 1.7%
51,487 $5.74 Million
Q1 2022

Apr 12, 2022

BUY
$93.1 - $112.54 $66,101 - $79,903
710 Added 1.37%
52,380 $5.82 Million
Q4 2021

Jan 24, 2022

SELL
$95.88 - $117.08 $9,588 - $11,708
-100 Reduced 0.19%
51,670 $5.79 Million
Q3 2021

Oct 07, 2021

SELL
$84.42 - $106.62 $62,808 - $79,325
-744 Reduced 1.42%
51,770 $4.97 Million
Q2 2021

Aug 05, 2021

BUY
$67.66 - $84.76 $405 - $508
6 Added 0.01%
52,514 $4.4 Million
Q1 2021

Apr 09, 2021

BUY
$67.06 - $75.82 $94,554 - $106,906
1,410 Added 2.76%
52,508 $3.54 Million
Q4 2020

Feb 05, 2021

BUY
$63.89 - $73.8 $11,500 - $13,284
180 Added 0.35%
51,098 $3.57 Million
Q3 2020

Oct 06, 2020

BUY
$63.69 - $70.22 $2.1 Million - $2.32 Million
32,989 Added 184.0%
50,918 $3.54 Million
Q2 2020

Jul 09, 2020

BUY
$58.54 - $67.94 $556,130 - $645,430
9,500 Added 112.71%
17,929 $1.17 Million
Q1 2020

Apr 09, 2020

SELL
$49.46 - $64.78 $49 - $64
-1 Reduced 0.01%
8,429 $507,000
Q3 2019

Oct 08, 2019

SELL
$47.54 - $53.43 $4,754 - $5,343
-100 Reduced 1.17%
8,430 $436,000
Q2 2019

Jul 11, 2019

BUY
$46.79 - $52.47 $2,339 - $2,623
50 Added 0.59%
8,530 $435,000
Q1 2019

Apr 12, 2019

SELL
$46.36 - $52.63 $4,867 - $5,526
-105 Reduced 1.22%
8,480 $444,000
Q4 2018

Jan 15, 2019

BUY
$41.54 - $47.25 $122,543 - $139,387
2,950 Added 52.35%
8,585 $396,000
Q3 2018

Oct 09, 2018

BUY
$46.76 - $51.24 $263,492 - $288,737
5,635 New
5,635 $266,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Ipswich Investment Management Co., Inc. Portfolio

Follow Ipswich Investment Management Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ipswich Investment Management Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ipswich Investment Management Co., Inc. with notifications on news.